Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing nerve stimulation and steroid injections for chronic knee pain

Official title: Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study

Run by M.D. Anderson Cancer Center · NCT06004882 · Data updated 2026-11-12

This study is testing whether nerve stimulation therapy works better than steroid injections for improving knee movement in people with chronic knee pain.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorM.D. Anderson Cancer Center
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedAugust 10, 2023
Main results expectedJanuary 31, 2027
Study endsJanuary 31, 2027
Registry record updatedAugust 12, 2026
Trial IDNCT06004882 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-85 with chronic knee pain and a baseline pain score of 4 or higher.

Probably not a fit

Patients with cognitive dysfunction, recent substance abuse, or specific allergies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of peripheral nerve stimulation (PNS) therapy compared to conventional steroid injections in improving knee range of motion for patients suffering from chronic knee pain. Participants will be randomly assigned to receive either a standard steroid injection, PNS therapy combined with a steroid injection, or PNS therapy with a placebo injection. The primary outcome will be measured using goniometry to assess changes in knee range of motion at 30, 60, and 90 days post-treatment, alongside secondary outcomes including pain scores and opioid usage. The study is conducted at the Pain Management Center at MD Anderson Cancer Center.

Why it matters

Potential benefit: If successful, this study could provide a new therapeutic option for patients with chronic knee pain, potentially improving their quality of life.

How similar studies have gone: While peripheral nerve stimulation has been explored in other contexts, this specific comparison with steroid injections is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with chronic knee pain (baseline pain score \>=4), seen at Pain Management Center at MD Anderson Cancer Center; if patient has bilateral knee pain, the side with the more severe knee pain will be treated first and counted towards the primary and secondary endpoints
* Patients between ages 18-85 years old
* Patient signed informed consent

Exclusion Criteria:

* Patients with cognitive dysfunction or without capacity to consent
* Patient with recent history (\<6 months) of drug or alcohol abuse
* Patients with open skin lesion or undergoing antibiotic therapy for local for systemic infection
* Patients with allergies to local anesthesia, steroids, or adhesives
* Patients who are on opioids for reasons other than knee pain

Where it's running

  • M D Anderson Cancer Center
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.